
FDA Approves Moderna’s New COVID-19 Vaccine for Seniors and High-Risk Groups
The U.S. Food and Drug Administration (FDA) has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults aged 65 and older, the company announced Saturday. The approval is the first since